Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M McShane

Showing results (51-60 of 306) with videos related to

Pageof 31
Sort By:
Fertility and Sterility|March 1, 1988
Severe thigh myositis following intramuscular progesterone injections in an in vitro fertilization patientW R Phipps, C B Benson, P M McShane
Biostatistics (Oxford, England)|June 22, 2017
Discussion: The role, position, and function of the FDA-The past, present, and futureThomas R Fleming, David L Demets, Lisa M McShane
Clinical Trials (London, England)|October 5, 2019
RejoinderLingyun Ji, Lisa M McShane, Mark Krailo, et al.
Clinical Trials (London, England)|October 5, 2019
Bias in retrospective analyses of biomarker effect using data from an outcome-adaptive randomized trialLingyun Ji, Lisa M McShane, Mark Krailo, et al.
Statistics in Medicine|October 30, 2004
Assessing surrogates as trial endpoints using mixed modelsEdward L Korn, Paul S Albert, Lisa M McShane
Statistics in Medicine|June 30, 1997
A comparison of spatial prediction techniques for an exploratory analysis of human cortical motor representationsL M McShane, K L Meier, E M Wassermann
Bioanalysis|June 21, 2018
Biomarkers in early-phase trials: fundamental issuesLaura M Yee, Tracy G Lively, Lisa M McShane
The Physician and Sportsmedicine|January 21, 2010
Femoral head contusion without hip dislocation: low-energy trauma in a female basketball playerSean T Bryan, John M McShane, Mark E Schweitzer
Primary Care|November 17, 2004
Physical examination of the shoulder in the primary care settingJohn M McShane, Michael J Graveley, Bruce D Hopper
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 23, 2015
Statistical controversies in clinical research: assessing pathologic complete response as a trial-level surrogate end point for early-stage breast cancerE L Korn, M C Sachs, L M McShane
Pageof 31

Showing results (51-60 of 306) with videos related to

Sort By:
Pageof 31
Fertility and Sterility|March 1, 1988
Severe thigh myositis following intramuscular progesterone injections in an in vitro fertilization patientW R Phipps, C B Benson, P M McShane
Biostatistics (Oxford, England)|June 22, 2017
Discussion: The role, position, and function of the FDA-The past, present, and futureThomas R Fleming, David L Demets, Lisa M McShane
Clinical Trials (London, England)|October 5, 2019
RejoinderLingyun Ji, Lisa M McShane, Mark Krailo, et al.
Clinical Trials (London, England)|October 5, 2019
Bias in retrospective analyses of biomarker effect using data from an outcome-adaptive randomized trialLingyun Ji, Lisa M McShane, Mark Krailo, et al.
Statistics in Medicine|October 30, 2004
Assessing surrogates as trial endpoints using mixed modelsEdward L Korn, Paul S Albert, Lisa M McShane
Statistics in Medicine|June 30, 1997
A comparison of spatial prediction techniques for an exploratory analysis of human cortical motor representationsL M McShane, K L Meier, E M Wassermann
Bioanalysis|June 21, 2018
Biomarkers in early-phase trials: fundamental issuesLaura M Yee, Tracy G Lively, Lisa M McShane
The Physician and Sportsmedicine|January 21, 2010
Femoral head contusion without hip dislocation: low-energy trauma in a female basketball playerSean T Bryan, John M McShane, Mark E Schweitzer
Primary Care|November 17, 2004
Physical examination of the shoulder in the primary care settingJohn M McShane, Michael J Graveley, Bruce D Hopper
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 23, 2015
Statistical controversies in clinical research: assessing pathologic complete response as a trial-level surrogate end point for early-stage breast cancerE L Korn, M C Sachs, L M McShane
Pageof 31